Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06723080 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Phase III Clinical Study of VC005 Tablets in Adult Patients With Moderate to Severe Atopic Dermatitis

Name: Phase III Clinical Study of VC005 Tablets in Adult Patients With Moderate to Severe Atopic Dermatitis — clinical trial record (NCT06723080)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhasePhase 3

SponsorJiangsu vcare pharmaceutical technology co., LTD

Started2024-12-30

View on ClinicalTrials.gov ↗

Amendment history

2026-07-23

Study Status, Oversight v2

Re-verified, no change to tracked fields

2025-02-07

Not Yet Recruiting→Recruiting Study Status, Oversight, Contacts/Locations v1

Trial statusNot Yet Recruiting→Recruiting

Study sitesdetails revised at 1 of 1 site

2024-12-05

Original filing

Jiangsu vcare pharmaceutical technology co., LTD

17 trials monitored

See all monitored trials

Atopic Dermatitis

489 trials monitored

See 14 trials at risk

This clinical trial is a multicenter, randomized, double-blind, controlled phase III clinical study

Trial Details

NCT Number	NCT06723080
Lead Sponsor	Jiangsu vcare pharmaceutical technology co., LTD
Conditions	Moderate to Severe Atopic Dermatitis
Enrollment	480 participants
Start Date	2024-12-30
Primary Completion	2027-08-30 (estimated)
Study Completion	2027-08-30 (estimated)
Updated on ClinicalTrials.gov	2026-07-27